Literature DB >> 21219974

Quantification of reserve pool dopamine in methionine sulfoxide reductase A null mice.

A N Ortiz1, D B Oien, J Moskovitz, M A Johnson.   

Abstract

Methionine sulfoxide reductase A knockout (MsrA-/-) mice, which serve as a potential model for neurodegeneration, suffer from increased oxidative stress and have previously been found to have chronically elevated brain dopamine (DA) content levels relative to control mice. Additionally, these high levels parallel the increased presynaptic DA release. In this study, fast-scan cyclic voltammetry (FSCV) at carbon-fiber microelectrodes was used to quantify striatal reserve pool DA in knockout mice and wild-type control mice. Reserve pool DA efflux, induced by amphetamine (AMPH), was measured in brain slices from knockout and wild type (WT) mice in the presence of α-methyl-p-tyrosine, a DA synthesis inhibitor. Additionally, the stimulated release of reserve pool DA, mobilized by cocaine (COC), was measured. Both efflux and stimulated release measurements were enhanced in slices from knockout mice, suggesting that these mice have greater reserve pool DA stores than wild-type and that these stores are effectively mobilized. Moreover, dopamine transporter (DAT) labeling data indicate that the difference in measured DA efflux was likely not caused by altered DAT protein expression. Additionally, slices from MsrA-/- and wild-type mice were equally responsive to increasing extracellular calcium concentrations, suggesting that potential differences in either calcium entry or intracellular calcium handling are not responsible for increased reserve pool DA release. Collectively, these results demonstrate that MsrA-/- knockout mice maintain a larger DA reserve pool than wild-type control mice, and that this pool is readily mobilized.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21219974      PMCID: PMC3449094          DOI: 10.1016/j.neuroscience.2011.01.001

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  41 in total

1.  Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals.

Authors:  J Moskovitz; S Bar-Noy; W M Williams; J Requena; B S Berlett; E R Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

Review 2.  Reactive oxygen species: stuck in the middle of neurodegeneration.

Authors:  David A Patten; Marc Germain; Melissa A Kelly; Ruth S Slack
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Dopamine D(2) receptor function is compromised in the brain of the methionine sulfoxide reductase A knockout mouse.

Authors:  Derek B Oien; Andrea N Ortiz; Alexander G Rittel; Rick T Dobrowsky; Michael A Johnson; Beth Levant; Stephen C Fowler; Jackob Moskovitz
Journal:  J Neurochem       Date:  2010-03-31       Impact factor: 5.372

Review 4.  Short-term synaptic plasticity.

Authors:  Robert S Zucker; Wade G Regehr
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

Review 5.  Molecular motors involved in chromaffin cell secretion.

Authors:  Sergio D Rosé; Tatiana Lejen; Luciana Casaletti; Roy E Larson; Teodora Dumitrescu Pene; José-María Trifaró
Journal:  Ann N Y Acad Sci       Date:  2002-10       Impact factor: 5.691

6.  Dopamine modulates synaptic transmission in the nucleus of the solitary tract.

Authors:  David D Kline; Kristin N Takacs; Eckhard Ficker; Diana L Kunze
Journal:  J Neurophysiol       Date:  2002-11       Impact factor: 2.714

7.  H(2)O(2) is a novel, endogenous modulator of synaptic dopamine release.

Authors:  B T Chen; M V Avshalumov; M E Rice
Journal:  J Neurophysiol       Date:  2001-06       Impact factor: 2.714

8.  A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation.

Authors:  Jeffrey R Erickson; Mei-ling A Joiner; Xiaoqun Guan; William Kutschke; Jinying Yang; Carmine V Oddis; Ryan K Bartlett; John S Lowe; Susan E O'Donnell; Nukhet Aykin-Burns; Matthew C Zimmerman; Kathy Zimmerman; Amy-Joan L Ham; Robert M Weiss; Douglas R Spitz; Madeline A Shea; Roger J Colbran; Peter J Mohler; Mark E Anderson
Journal:  Cell       Date:  2008-05-02       Impact factor: 41.582

9.  Clearance and phosphorylation of alpha-synuclein are inhibited in methionine sulfoxide reductase a null yeast cells.

Authors:  Derek B Oien; Heather E Shinogle; David S Moore; Jackob Moskovitz
Journal:  J Mol Neurosci       Date:  2009-08-04       Impact factor: 3.444

10.  Caloric restriction alleviates abnormal locomotor activity and dopamine levels in the brain of the methionine sulfoxide reductase A knockout mouse.

Authors:  Derek B Oien; Gregory L Osterhaus; Brandi L Lundquist; Stephen C Fowler; Jackob Moskovitz
Journal:  Neurosci Lett       Date:  2009-10-23       Impact factor: 3.046

View more
  3 in total

1.  Hyperglycemia and redox status regulate RUNX2 DNA-binding and an angiogenic phenotype in endothelial cells.

Authors:  Maria T Mochin; Karen F Underwood; Brandon Cooper; John C McLenithan; Adam D Pierce; Cesar Nalvarte; Jack Arbiser; Anna I Karlsson; Alexander R Moise; Jackob Moskovitz; Antonino Passaniti
Journal:  Microvasc Res       Date:  2014-10-02       Impact factor: 3.514

2.  In Situ Electrochemical Monitoring of Caged Compound Photochemistry: An Internal Actinometer for Substrate Release.

Authors:  Romana Jarosova; Sam V Kaplan; Thomas M Field; Richard S Givens; Sanjeewa N Senadheera; Michael A Johnson
Journal:  Anal Chem       Date:  2021-01-25       Impact factor: 6.986

3.  Impaired Brain Dopamine and Serotonin Release and Uptake in Wistar Rats Following Treatment with Carboplatin.

Authors:  Sam V Kaplan; Ryan A Limbocker; Rachel C Gehringer; Jenny L Divis; Gregory L Osterhaus; Maxwell D Newby; Michael J Sofis; David P Jarmolowicz; Brooke D Newman; Tiffany A Mathews; Michael A Johnson
Journal:  ACS Chem Neurosci       Date:  2016-05-22       Impact factor: 4.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.